We're inviting our clients and friends to join us for:
Opportunities and Challenges in the
Women’s Health Market
a panel discussion
October 17, 2007
8:00 a.m. ~ Registration and Breakfast
8:30 a.m. ~ Program
at the offices of
Mintz Levin
One Financial Center
Boston, Massachusetts 02111
The country is responding to the unique concerns of women and their health.
Approximately 75% of autoimmune diseases occur in women. More than two-thirds of the 44 million Americans suffering from osteoporosis are women. And because women live longer than men, they are more likely to suffer from age-related illnesses like Alzheimer’s, heart failure and Parkinson’s. As a result, women need more preventative and diagnostic care, including imaging and genetic testing and other screening processes.
Join local thought leaders from the women’s healthcare industry to discuss emerging trends in women’s healthcare medical technology.
OUR PANEL INCLUDES:
Megan Gates, Attorney, Mintz Levin (Moderator)
Megan Gates is co-chair of Mintz Levin’s Securities Practice Group. She focuses on the biotechnology, healthcare and life sciences industries. Recent transactions include the initial public offerings of Altus Pharmaceuticals Inc., Coley Pharmaceutical Group, Inc., and Targacept, Inc., the tender offer by QIAGEN N.V. for Digene Corporation, and the acquisition by Caliper Life Sciences, Inc. of Xenogen Corporation. Megan was formerly in-house at Thermo Electron Corporation (now Thermo Fisher Scientific Inc.).
Timothy Adams, SVP, CFO and Treasurer, Cytyc Corporation
Timothy Adams joined Cytyc Corporation, a leading medical device company focused on women’s health, in 2004. He has more than twenty years of strong financial leadership experience with worldwide experience in finance, operations, treasury, tax, human resources and information technology.
Teresa Prego, Director, Boston Scientific Women’s Health
Teresa Prego joined Boston Scientific, a leading medical device company with multiple franchises, including Women’s Health, in 2004. She has more than 16 years of experience in the healthcare industry, both as a consultant and in industry, holding roles in global product marketing, strategic marketing and business development for major healthcare companies, including Chiron, Bayer and Inverness Medical Innovations.
Olivia Ho Cheng, CEO and President, Aurora Imaging Technology
Olivia Ho Cheng is the President and CEO of Aurora Imaging Technology, Inc., a company that is revolutionizing breast cancer detection and diagnosis with the Aurora 1.5 Tesla Dedicated Breast MRI System with Bilateral SpiralRODEO, the only dedicated FDA-cleared breast MRI system designed specifically and exclusively for breast imaging. Ms. Cheng has served on the boards of medical device companies Accuray Incorporated (NASDAQ “ARAY” with market capitalization exceeding $1 billion and known for its CyberKnife System) and The Trylon Corporation known for its cervical cancer-detecting procedure, PapSure.
Tom Cibotti, Managing Director, Covington Associates
Tom Cibotti has over 20 years of experience in investment banking, including 14 years at Covington Associates, a specialty investment banking firm focusing on middle market business service, consumer and industrial, healthcare, and technology companies. Tom has advised on numerous healthcare M&A transactions, including deals within the women’s health arena.